Suppr超能文献

营养诱导的人体肝脏脂肪含量变化

Nutrient-Induced Changes of Liver Fat Content in Humans.

作者信息

Kovář J, Poledne R

机构信息

Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

出版信息

Physiol Res. 2025 Apr 30;74(2):163-174. doi: 10.33549/physiolres.935525.

Abstract

Metabolic-dysfunction associated steatotic liver disease (MASLD) affects approximately 30 % of the world adult population and even contributes to the increased mortality from cardiovascular disease. Dietary intervention, along with exercise, is the most important tool for the treatment of MASLD patients. Dietary composition can have profound effects on liver fat. This review summarizes the results of studies that used MR methods to study the effect of macronutrients on liver fat content. It focuses on intervention studies manipulating the content and quantity of macronutrients in long-term dietary intervention studies and, in more detail, on studies monitoring the effect of administered nutrients on changes in liver fat over several hours.

摘要

代谢功能障碍相关脂肪性肝病(MASLD)影响着全球约30%的成年人口,甚至导致心血管疾病死亡率上升。饮食干预与运动一起,是治疗MASLD患者最重要的手段。饮食组成可对肝脏脂肪产生深远影响。本综述总结了使用磁共振方法研究常量营养素对肝脏脂肪含量影响的研究结果。它侧重于长期饮食干预研究中操纵常量营养素含量和数量的干预研究,更详细地说,侧重于监测数小时内给予的营养素对肝脏脂肪变化影响的研究。

相似文献

1
Nutrient-Induced Changes of Liver Fat Content in Humans.
Physiol Res. 2025 Apr 30;74(2):163-174. doi: 10.33549/physiolres.935525.
2
Influence of Lipid Class Used for Omega-3 Fatty Acid Supplementation on Liver Fat Accumulation in MASLD.
Physiol Res. 2024 Aug 31;73(Suppl 1):S295-S320. doi: 10.33549/physiolres.935396. Epub 2024 Jul 17.
3
Macronutrients and the Adipose-Liver Axis in Obesity and Fatty Liver.
Cell Mol Gastroenterol Hepatol. 2019;7(4):749-761. doi: 10.1016/j.jcmgh.2019.02.001. Epub 2019 Feb 11.
7
Metabolic dysfunction-associated steatotic liver disease: A story of muscle and mass.
World J Gastroenterol. 2025 May 28;31(20):105346. doi: 10.3748/wjg.v31.i20.105346.
8
Combination of dietary fiber and exercise training improves fat loss in mice but does not ameliorate MASLD more than exercise alone.
Am J Physiol Gastrointest Liver Physiol. 2025 Apr 1;328(4):G399-G410. doi: 10.1152/ajpgi.00317.2024. Epub 2025 Mar 4.
9
Serum metabolic signatures and MetalnFF diagnostic score for mild and moderate metabolic dysfunction-associated steatotic liver disease.
J Pharm Biomed Anal. 2025 Aug 1;260:116772. doi: 10.1016/j.jpba.2025.116772. Epub 2025 Feb 25.

本文引用的文献

3
Influence of Lipid Class Used for Omega-3 Fatty Acid Supplementation on Liver Fat Accumulation in MASLD.
Physiol Res. 2024 Aug 31;73(Suppl 1):S295-S320. doi: 10.33549/physiolres.935396. Epub 2024 Jul 17.
5
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications.
Gut. 2024 Mar 7;73(4):691-702. doi: 10.1136/gutjnl-2023-330595.
8
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.
Hepatology. 2023 Apr 1;77(4):1335-1347. doi: 10.1097/HEP.0000000000000004. Epub 2023 Jan 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验